XML 53 R29.htm IDEA: XBRL DOCUMENT
v3.19.3.a.u2

Condensed Consolidating Financial Information | 12 Months Ended
--- | ---
Dec. 31, 2019
Condensed Financial Information Disclosure [Abstract] |
Condensed Consolidating Financial Information | Condensed Consolidating Financial Information: The accompanying condensed consolidating financial information has been prepared and presented pursuant to SEC Regulation S-X, Rule 3-10, “Financial Statements of Guarantors and Issuers of Guaranteed Securities Registered or Being Registered.” Each of the subsidiary guarantors is 100% owned by Encompass Health, and all guarantees are full and unconditional and joint and several, subject to certain customary conditions for release. Encompass Health’s investments in its consolidated subsidiaries, as well as guarantor subsidiaries’ investments in nonguarantor subsidiaries and nonguarantor subsidiaries’ investments in guarantor subsidiaries, are presented under the equity method of accounting with the related investment presented within the line items Intercompany receivable and Intercompany payable in the accompanying condensed consolidating balance sheets. The terms of our credit agreement allow us to declare and pay cash dividends on our common stock so long as: (1) we are not in default under our credit agreement and (2) our senior secured leverage ratio (as defined in our credit agreement) remains less than or equal to 2 x. The terms of our senior note indenture allow us to declare and pay cash dividends on our common stock so long as (1) we are not in default, (2) the consolidated coverage ratio (as defined in the indenture) exceeds 2 x or we are otherwise allowed under the indenture to incur debt, and (3) we have capacity under the indenture’s restricted payments covenant to declare and pay dividends. See Note 10, Long-term Debt. Periodically, certain wholly owned subsidiaries of Encompass Health make dividends or distributions of available cash and/or intercompany receivable balances to their parents. In addition, Encompass Health makes contributions to certain wholly owned subsidiaries. When made, these dividends, distributions, and contributions impact the Intercompany receivable, Intercompany payable, and Encompass Health shareholders’ equity line items in the accompanying condensed consolidating balance sheet but have no impact on the consolidated financial statements of Encompass Health Corporation. The “Holdings” column in the condensed consolidating financial statements below represents Holdings and its wholly-owned subsidiaries. As discussed in Note 12, Redeemable Noncontrolling Interests, Holdings had 5.5% noncontrolling interest as of December 31, 2019, and accordingly, Holdings and its wholly-owned subsidiaries were not guarantors of our debt. In February 2020, we acquired for cash all but 1.2% of the remaining noncontrolling interest in Holdings following the most recent exercise of the put option by the management investors. On February 20, 2020, Encompass Health Corporation and each of the two remaining management investors agreed to exchange the remaining shares representing the noncontrolling interest for an equal value of shares of common stock of Encompass Health Corporation. We expect to settle the exchanges in March 2020.
| For the Year Ended December 31, 2019
| Encompass Health Corporation |  | Guarantor Subsidiaries |  | Non-guarantor Subsidiaries |  | Holdings |  | Eliminating Entries |  | Encompass Health Consolidated
| (In Millions)
Net operating revenues | $ | 20.7 |  |  | $ | 2,425.5 |  |  | $ | 1,221.7 |  |  | $ | 1,074.1 |  |  | $ | (137.0 | ) |  | $ | 4,605.0 |
Operating expenses: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Salaries and benefits | 59.6 |  |  | 1,176.5 |  |  | 608.7 |  |  | 748.9 |  |  | (20.7 | ) |  | 2,573.0 |
Other operating expenses | 45.0 |  |  | 351.8 |  |  | 189.3 |  |  | 88.4 |  |  | (50.9 | ) |  | 623.6 |
Occupancy costs | 2.1 |  |  | 100.8 |  |  | 27.5 |  |  | 17.3 |  |  | (65.4 | ) |  | 82.3 |
Supplies | — |  |  | 98.0 |  |  | 49.3 |  |  | 20.6 |  |  | — |  |  | 167.9 |
General and administrative expenses | 160.0 |  |  | — |  |  | — |  |  | 87.0 |  |  | — |  |  | 247.0 |
Depreciation and amortization | 19.9 |  |  | 106.8 |  |  | 54.9 |  |  | 37.1 |  |  | — |  |  | 218.7 |
Total operating expenses | 286.6 |  |  | 1,833.9 |  |  | 929.7 |  |  | 999.3 |  |  | (137.0 | ) |  | 3,912.5 |
Loss on early extinguishment of debt | 7.7 |  |  | — |  |  | — |  |  | — |  |  | — |  |  | 7.7 |
Interest expense and amortization of debt discounts and fees | 131.0 |  |  | 24.7 |  |  | 5.6 |  |  | 28.4 |  |  | (30.0 | ) |  | 159.7 |
Other income | (32.3 | ) |  | (21.1 | ) |  | (7.1 | ) |  | — |  |  | 30.0 |  |  | (30.5 | )
Equity in net income of nonconsolidated affiliates | — |  |  | (5.1 | ) |  | (0.4 | ) |  | (1.2 | ) |  | — |  |  | (6.7 | )
Equity in net income of consolidated affiliates | (492.6 | ) |  | (67.0 | ) |  | — |  |  | — |  |  | 559.6 |  |  | — |
Management fees | (160.8 | ) |  | 117.8 |  |  | 43.0 |  |  | — |  |  | — |  |  | — |
Income from continuing operations before income tax (benefit) expense | 281.1 |  |  | 542.3 |  |  | 250.9 |  |  | 47.6 |  |  | (559.6 | ) |  | 562.3 |
Provision for income tax (benefit) expense | (78.2 | ) |  | 140.3 |  |  | 40.3 |  |  | 13.5 |  |  | — |  |  | 115.9 |
Income from continuing operations | 359.3 |  |  | 402.0 |  |  | 210.6 |  |  | 34.1 |  |  | (559.6 | ) |  | 446.4 |
Loss from discontinued operations, net of tax | (0.6 | ) |  | — |  |  | — |  |  | — |  |  | — |  |  | (0.6 | )
Net income | 358.7 |  |  | 402.0 |  |  | 210.6 |  |  | 34.1 |  |  | (559.6 | ) |  | 445.8 |
Less: Net income attributable to noncontrolling interests | — |  |  | — |  |  | (83.3 | ) |  | (3.8 | ) |  | — |  |  | (87.1 | )
Net income attributable to Encompass Health | $ | 358.7 |  |  | $ | 402.0 |  |  | $ | 127.3 |  |  | $ | 30.3 |  |  | $ | (559.6 | ) |  | $ | 358.7 |
Comprehensive income | $ | 358.7 |  |  | $ | 402.0 |  |  | $ | 210.6 |  |  | $ | 34.1 |  |  | $ | (559.6 | ) |  | $ | 445.8 |
Comprehensive income attributable to Encompass Health | $ | 358.7 |  |  | $ | 402.0 |  |  | $ | 127.3 |  |  | $ | 30.3 |  |  | $ | (559.6 | ) |  | $ | 358.7 |
| For the Year Ended December 31, 2018
| Encompass Health Corporation |  | Guarantor Subsidiaries |  | Non-guarantor Subsidiaries |  | Holdings |  | Eliminating Entries |  | Encompass Health Consolidated
| (In Millions)
Net operating revenues | $ | 21.0 |  |  | $ | 2,351.8 |  |  | $ | 1,118.9 |  |  | $ | 915.9 |  |  | $ | (130.3 | ) |  | $ | 4,277.3 |
Operating expenses: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Salaries and benefits | 49.5 |  |  | 1,132.2 |  |  | 550.4 |  |  | 643.3 |  |  | (21.4 | ) |  | 2,354.0 |
Other operating expenses | 37.9 |  |  | 344.3 |  |  | 177.4 |  |  | 75.3 |  |  | (49.8 | ) |  | 585.1 |
Occupancy costs | 1.9 |  |  | 95.7 |  |  | 25.4 |  |  | 14.1 |  |  | (59.1 | ) |  | 78.0 |
Supplies | — |  |  | 95.8 |  |  | 44.9 |  |  | 18.0 |  |  | — |  |  | 158.7 |
General and administrative expenses | 161.0 |  |  | — |  |  | — |  |  | 59.2 |  |  | — |  |  | 220.2 |
Depreciation and amortization | 14.3 |  |  | 108.2 |  |  | 47.6 |  |  | 29.6 |  |  | — |  |  | 199.7 |
Government, class action, and related settlements | 52.0 |  |  | — |  |  | — |  |  | — |  |  | — |  |  | 52.0 |
Total operating expenses | 316.6 |  |  | 1,776.2 |  |  | 845.7 |  |  | 839.5 |  |  | (130.3 | ) |  | 3,647.7 |
Interest expense and amortization of debt discounts and fees | 124.2 |  |  | 22.6 |  |  | 2.2 |  |  | 23.5 |  |  | (25.2 | ) |  | 147.3 |
Other income | (22.4 | ) |  | (1.0 | ) |  | (3.5 | ) |  | (0.5 | ) |  | 25.2 |  |  | (2.2 | )
Equity in net income of nonconsolidated affiliates | — |  |  | (7.1 | ) |  | (0.4 | ) |  | (1.2 | ) |  | — |  |  | (8.7 | )
Equity in net income of consolidated affiliates | (465.6 | ) |  | (63.4 | ) |  | — |  |  | — |  |  | 529.0 |  |  | — |
Management fees | (153.1 | ) |  | 114.0 |  |  | 39.1 |  |  | — |  |  | — |  |  | — |
Income from continuing operations before income tax (benefit) expense | 221.3 |  |  | 510.5 |  |  | 235.8 |  |  | 54.6 |  |  | (529.0 | ) |  | 493.2 |
Provision for income tax (benefit) expense | (69.9 | ) |  | 136.6 |  |  | 38.4 |  |  | 13.8 |  |  | — |  |  | 118.9 |
Income from continuing operations | 291.2 |  |  | 373.9 |  |  | 197.4 |  |  | 40.8 |  |  | (529.0 | ) |  | 374.3 |
Income from discontinued operations, net of tax | 1.1 |  |  | — |  |  | — |  |  | — |  |  | — |  |  | 1.1 |
Net income | 292.3 |  |  | 373.9 |  |  | 197.4 |  |  | 40.8 |  |  | (529.0 | ) |  | 375.4 |
Less: Net income attributable to noncontrolling interests | — |  |  | — |  |  | (77.8 | ) |  | (5.3 | ) |  | — |  |  | (83.1 | )
Net income attributable to Encompass Health | $ | 292.3 |  |  | $ | 373.9 |  |  | $ | 119.6 |  |  | $ | 35.5 |  |  | $ | (529.0 | ) |  | $ | 292.3 |
Comprehensive income | $ | 292.3 |  |  | $ | 373.9 |  |  | $ | 197.4 |  |  | $ | 40.8 |  |  | $ | (529.0 | ) |  | $ | 375.4 |
Comprehensive income attributable to Encompass Health | $ | 292.3 |  |  | $ | 373.9 |  |  | $ | 119.6 |  |  | $ | 35.5 |  |  | $ | (529.0 | ) |  | $ | 292.3 |
| For the Year Ended December 31, 2017
| Encompass Health Corporation |  | Guarantor Subsidiaries |  | Non-guarantor Subsidiaries |  | Holdings |  | Eliminating Entries |  | Encompass Health Consolidated
| (In Millions)
Net operating revenues | $ | 21.3 |  |  | $ | 2,252.5 |  |  | $ | 1,006.4 |  |  | $ | 759.8 |  |  | $ | (126.1 | ) |  | $ | 3,913.9 |
Operating expenses: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Salaries and benefits | 34.7 |  |  | 1,088.7 |  |  | 508.9 |  |  | 543.3 |  |  | (21.0 | ) |  | 2,154.6 |
Other operating expenses | 32.8 |  |  | 324.8 |  |  | 160.2 |  |  | 62.4 |  |  | (48.6 | ) |  | 531.6 |
Occupancy costs | 1.9 |  |  | 93.7 |  |  | 23.0 |  |  | 11.4 |  |  | (56.5 | ) |  | 73.5 |
Supplies | — |  |  | 94.2 |  |  | 41.7 |  |  | 13.4 |  |  | — |  |  | 149.3 |
General and administrative | 143.7 |  |  | — |  |  | — |  |  | 28.0 |  |  | — |  |  | 171.7 |
Depreciation and amortization | 8.8 |  |  | 106.6 |  |  | 44.7 |  |  | 23.7 |  |  | — |  |  | 183.8 |
Total operating expenses | 221.9 |  |  | 1,708.0 |  |  | 778.5 |  |  | 682.2 |  |  | (126.1 | ) |  | 3,264.5 |
Loss on early extinguishment of debt | 10.7 |  |  | — |  |  | — |  |  | — |  |  | — |  |  | 10.7 |
Interest expense and amortization of debt discounts and fees | 130.5 |  |  | 23.2 |  |  | 2.5 |  |  | 19.2 |  |  | (21.0 | ) |  | 154.4 |
Other (income) loss | (21.7 | ) |  | 0.2 |  |  | (3.6 | ) |  | — |  |  | 21.0 |  |  | (4.1 | )
Equity in net income of nonconsolidated affiliates | — |  |  | (6.9 | ) |  | (0.4 | ) |  | (0.7 | ) |  | — |  |  | (8.0 | )
Equity in net income of consolidated affiliates | (342.1 | ) |  | (39.0 | ) |  | — |  |  | — |  |  | 381.1 |  |  | — |
Management fees | (145.0 | ) |  | 109.5 |  |  | 35.5 |  |  | — |  |  | — |  |  | — |
Income from continuing operations before income tax (benefit) expense | 167.0 |  |  | 457.5 |  |  | 193.9 |  |  | 59.1 |  |  | (381.1 | ) |  | 496.4 |
Provision for income tax (benefit) expense | (104.5 | ) |  | 182.6 |  |  | 66.8 |  |  | 0.9 |  |  | — |  |  | 145.8 |
Income from continuing operations | 271.5 |  |  | 274.9 |  |  | 127.1 |  |  | 58.2 |  |  | (381.1 | ) |  | 350.6 |
Loss from discontinued operations, net of tax | (0.4 | ) |  | — |  |  | — |  |  | — |  |  | — |  |  | (0.4 | )
Net income | 271.1 |  |  | 274.9 |  |  | 127.1 |  |  | 58.2 |  |  | (381.1 | ) |  | 350.2 |
Less: Net income attributable to noncontrolling interests | — |  |  | — |  |  | (68.7 | ) |  | (10.4 | ) |  | — |  |  | (79.1 | )
Net income attributable to Encompass Health | $ | 271.1 |  |  | $ | 274.9 |  |  | $ | 58.4 |  |  | $ | 47.8 |  |  | $ | (381.1 | ) |  | $ | 271.1 |
Comprehensive income | $ | 271.0 |  |  | $ | 274.9 |  |  | $ | 127.1 |  |  | $ | 58.2 |  |  | $ | (381.1 | ) |  | $ | 350.1 |
Comprehensive income attributable to Encompass Health | $ | 271.0 |  |  | $ | 274.9 |  |  | $ | 58.4 |  |  | $ | 47.8 |  |  | $ | (381.1 | ) |  | $ | 271.0 |
| As of December 31, 2019
| Encompass Health Corporation |  | Guarantor Subsidiaries |  | Non-guarantor Subsidiaries |  | Holdings |  | Eliminating Entries |  | Encompass Health Consolidated
| (In Millions)
Assets |  |  |  |  |  |  |  |  |  |  |
Current assets: |  |  |  |  |  |  |  |  |  |  |
Cash and cash equivalents | $ | 53.7 |  |  | $ | 5.2 |  |  | $ | 6.0 |  |  | $ | 29.9 |  |  | $ | — |  |  | $ | 94.8 |
Restricted cash | — |  |  | — |  |  | 57.4 |  |  | — |  |  | — |  |  | 57.4 |
Accounts receivable | — |  |  | 280.4 |  |  | 125.6 |  |  | 100.1 |  |  | — |  |  | 506.1 |
Prepaid expenses and other current assets | 64.3 |  |  | 35.4 |  |  | 9.3 |  |  | 7.8 |  |  | (19.3 | ) |  | 97.5 |
Total current assets | 118.0 |  |  | 321.0 |  |  | 198.3 |  |  | 137.8 |  |  | (19.3 | ) |  | 755.8 |
Property and equipment, net | 133.4 |  |  | 1,246.0 |  |  | 551.2 |  |  | 28.7 |  |  | — |  |  | 1,959.3 |
Operating lease right-of-use assets | 10.1 |  |  | 171.5 |  |  | 86.5 |  |  | 43.7 |  |  | (35.3 | ) |  | 276.5 |
Goodwill | — |  |  | 912.2 |  |  | 323.0 |  |  | 1,070.0 |  |  | — |  |  | 2,305.2 |
Intangible assets, net | 17.7 |  |  | 101.7 |  |  | 65.3 |  |  | 291.6 |  |  | — |  |  | 476.3 |
Deferred income tax assets | 27.2 |  |  | 11.1 |  |  | 0.1 |  |  | — |  |  | (35.5 | ) |  | 2.9 |
Other long-term assets | 53.6 |  |  | 85.4 |  |  | 151.6 |  |  | 14.1 |  |  | — |  |  | 304.7 |
Intercompany notes receivable | 737.8 |  |  | — |  |  | — |  |  | — |  |  | (737.8 | ) |  | — |
Intercompany receivable and investments in consolidated affiliates | 3,155.4 |  |  | 523.6 |  |  | — |  |  | — |  |  | (3,679.0 | ) |  | — |
Total assets | $ | 4,253.2 |  |  | $ | 3,372.5 |  |  | $ | 1,376.0 |  |  | $ | 1,585.9 |  |  | $ | (4,506.9 | ) |  | $ | 6,080.7 |
Liabilities and Shareholders’ Equity |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Current liabilities: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Current portion of long-term debt | $ | 17.0 |  |  | $ | 10.4 |  |  | $ | 3.8 |  |  | $ | 8.1 |  |  | $ | — |  |  | $ | 39.3 |
Current operating lease liabilities | 1.3 |  |  | 21.9 |  |  | 16.0 |  |  | 12.1 |  |  | (10.9 | ) |  | 40.4 |
Accounts payable | 9.8 |  |  | 56.5 |  |  | 24.3 |  |  | 4.0 |  |  | — |  |  | 94.6 |
Accrued payroll | 34.8 |  |  | 76.2 |  |  | 40.4 |  |  | 59.1 |  |  | — |  |  | 210.5 |
Accrued interest payable | 30.4 |  |  | 2.0 |  |  | — |  |  | — |  |  | — |  |  | 32.4 |
Other current liabilities | 82.2 |  |  | 30.5 |  |  | 68.8 |  |  | 141.6 |  |  | (19.3 | ) |  | 303.8 |
Total current liabilities | 175.5 |  |  | 197.5 |  |  | 153.3 |  |  | 224.9 |  |  | (30.2 | ) |  | 721.0 |
Long-term debt, net of current portion | 2,670.6 |  |  | 305.4 |  |  | 41.6 |  |  | 5.7 |  |  | — |  |  | 3,023.3 |
Long-term operating lease liabilities | 9.0 |  |  | 153.9 |  |  | 73.6 |  |  | 31.9 |  |  | (24.6 | ) |  | 243.8 |
Intercompany notes payable | — |  |  | — |  |  | — |  |  | 737.8 |  |  | (737.8 | ) |  | — |
Self-insured risks | 19.3 |  |  | — |  |  | 97.9 |  |  | — |  |  | — |  |  | 117.2 |
Other long-term liabilities | 26.6 |  |  | 12.2 |  |  | 2.4 |  |  | 37.0 |  |  | (35.5 | ) |  | 42.7 |
Intercompany payable | — |  |  | — |  |  | 66.0 |  |  | 4.4 |  |  | (70.4 | ) |  | — |
| 2,901.0 |  |  | 669.0 |  |  | 434.8 |  |  | 1,041.7 |  |  | (898.5 | ) |  | 4,148.0 |
Commitments and contingencies |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Redeemable noncontrolling interests | — |  |  | — |  |  | 31.4 |  |  | 208.2 |  |  | — |  |  | 239.6 |
Shareholders’ equity: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Encompass Health shareholders’ equity | 1,352.2 |  |  | 2,703.5 |  |  | 568.9 |  |  | 336.0 |  |  | (3,608.4 | ) |  | 1,352.2 |
Noncontrolling interests | — |  |  | — |  |  | 340.9 |  |  | — |  |  | — |  |  | 340.9 |
Total shareholders’ equity | 1,352.2 |  |  | 2,703.5 |  |  | 909.8 |  |  | 336.0 |  |  | (3,608.4 | ) |  | 1,693.1 |
Total liabilities and shareholders’ equity | $ | 4,253.2 |  |  | $ | 3,372.5 |  |  | $ | 1,376.0 |  |  | $ | 1,585.9 |  |  | $ | (4,506.9 | ) |  | $ | 6,080.7 |
| As of December 31, 2018
| Encompass Health Corporation |  | Guarantor Subsidiaries |  | Non-guarantor Subsidiaries |  | Holdings |  | Eliminating Entries |  | Encompass Health Consolidated
| (In Millions)
Assets |  |  |  |  |  |  |  |  |  |  |
Current assets: |  |  |  |  |  |  |  |  |  |  |
Cash and cash equivalents | $ | 41.5 |  |  | $ | 3.0 |  |  | $ | 5.1 |  |  | $ | 19.6 |  |  | $ | — |  |  | $ | 69.2 |
Restricted cash | — |  |  | — |  |  | 59.0 |  |  | — |  |  | — |  |  | 59.0 |
Accounts receivable | — |  |  | 270.7 |  |  | 121.6 |  |  | 75.4 |  |  | — |  |  | 467.7 |
Prepaid expenses and other current assets | 36.3 |  |  | 17.6 |  |  | 26.2 |  |  | 4.9 |  |  | (18.8 | ) |  | 66.2 |
Total current assets | 77.8 |  |  | 291.3 |  |  | 211.9 |  |  | 99.9 |  |  | (18.8 | ) |  | 662.1 |
Property and equipment, net | 123.9 |  |  | 1,041.5 |  |  | 445.2 |  |  | 24.2 |  |  | — |  |  | 1,634.8 |
Goodwill | — |  |  | 912.2 |  |  | 293.3 |  |  | 895.3 |  |  | — |  |  | 2,100.8 |
Intangible assets, net | 21.4 |  |  | 96.6 |  |  | 67.5 |  |  | 257.9 |  |  | — |  |  | 443.4 |
Deferred income tax assets | 47.9 |  |  | 28.9 |  |  | 0.1 |  |  | — |  |  | (34.0 | ) |  | 42.9 |
Other long-term assets | 47.9 |  |  | 100.4 |  |  | 130.9 |  |  | 11.8 |  |  | — |  |  | 291.0 |
Intercompany notes receivable | 535.3 |  |  | — |  |  | — |  |  | — |  |  | (535.3 | ) |  | — |
Intercompany receivable and investments in consolidated affiliates | 2,904.4 |  |  | 457.6 |  |  | — |  |  | — |  |  | (3,362.0 | ) |  | — |
Total assets | $ | 3,758.6 |  |  | $ | 2,928.5 |  |  | $ | 1,148.9 |  |  | $ | 1,289.1 |  |  | $ | (3,950.1 | ) |  | $ | 5,175.0 |
Liabilities and Shareholders’ Equity |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Current liabilities: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Current portion of long-term debt | $ | 35.0 |  |  | $ | 7.5 |  |  | $ | 4.4 |  |  | $ | 6.4 |  |  | $ | (17.5 | ) |  | $ | 35.8 |
Accounts payable | 8.9 |  |  | 46.4 |  |  | 30.4 |  |  | 4.3 |  |  | — |  |  | 90.0 |
Accrued payroll | 35.0 |  |  | 69.1 |  |  | 35.4 |  |  | 48.9 |  |  | — |  |  | 188.4 |
Accrued interest payable | 22.3 |  |  | 2.4 |  |  | — |  |  | — |  |  | (0.3 | ) |  | 24.4 |
Other current liabilities | 154.5 |  |  | 5.1 |  |  | 85.7 |  |  | 89.6 |  |  | (1.0 | ) |  | 333.9 |
Total current liabilities | 255.7 |  |  | 130.5 |  |  | 155.9 |  |  | 149.2 |  |  | (18.8 | ) |  | 672.5 |
Long-term debt, net of current portion | 2,188.7 |  |  | 262.1 |  |  | 20.0 |  |  | 7.8 |  |  | — |  |  | 2,478.6 |
Intercompany notes payable | — |  |  | — |  |  | — |  |  | 535.3 |  |  | (535.3 | ) |  | — |
Self-insured risks | 16.1 |  |  | — |  |  | 103.5 |  |  | — |  |  | — |  |  | 119.6 |
Other long-term liabilities | 21.4 |  |  | 17.1 |  |  | 5.0 |  |  | 76.0 |  |  | (33.9 | ) |  | 85.6 |
Intercompany payable | — |  |  | — |  |  | 48.9 |  |  | 4.2 |  |  | (53.1 | ) |  | — |
| 2,481.9 |  |  | 409.7 |  |  | 333.3 |  |  | 772.5 |  |  | (641.1 | ) |  | 3,356.3 |
Commitments and contingencies |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Redeemable noncontrolling interests | — |  |  | — |  |  | 38.3 |  |  | 223.4 |  |  | — |  |  | 261.7 |
Shareholders’ equity |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Encompass Health shareholders’ equity | 1,276.7 |  |  | 2,518.8 |  |  | 497.0 |  |  | 293.2 |  |  | (3,309.0 | ) |  | 1,276.7 |
Noncontrolling interests | — |  |  | — |  |  | 280.3 |  |  | — |  |  | — |  |  | 280.3 |
Total shareholders’ equity | 1,276.7 |  |  | 2,518.8 |  |  | 777.3 |  |  | 293.2 |  |  | (3,309.0 | ) |  | 1,557.0 |
Total liabilities and shareholders’ equity | $ | 3,758.6 |  |  | $ | 2,928.5 |  |  | $ | 1,148.9 |  |  | $ | 1,289.1 |  |  | $ | (3,950.1 | ) |  | $ | 5,175.0 |
| For the Year Ended December 31, 2019
| Encompass Health Corporation |  | Guarantor Subsidiaries |  | Non-guarantor Subsidiaries |  | Holdings |  | Eliminating Entries |  | Encompass Health Consolidated
| (In Millions)
Net cash (used in) provided by operating activities | $ | (110.8 | ) |  | $ | 450.3 |  |  | $ | 247.9 |  |  | $ | 47.9 |  |  | $ | — |  |  | $ | 635.3 |
Cash flows from investing activities: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Acquisition of businesses, net of cash acquired | (217.8 | ) |  | — |  |  | — |  |  | (13.7 | ) |  | — |  |  | (231.5 | )
Purchases of property and equipment | (38.6 | ) |  | (207.3 | ) |  | (117.9 | ) |  | (8.6 | ) |  | — |  |  | (372.4 | )
Additions to capitalized software costs | (7.4 | ) |  | (0.7 | ) |  | (1.4 | ) |  | (3.5 | ) |  | — |  |  | (13.0 | )
Purchases of intangible assets | — |  |  | (18.0 | ) |  | — |  |  | (0.7 | ) |  | — |  |  | (18.7 | )
Proceeds from sale of restricted investments | — |  |  | — |  |  | 17.6 |  |  | — |  |  | — |  |  | 17.6 |
Purchases of restricted investments | — |  |  | — |  |  | (30.9 | ) |  | (2.0 | ) |  | — |  |  | (32.9 | )
Funding of intercompany note receivable | (64.0 | ) |  | — |  |  | — |  |  | — |  |  | 64.0 |  |  | — |
Proceeds from repayment of intercompany note receivable | 93.0 |  |  | — |  |  | 17.5 |  |  | — |  |  | (110.5 | ) |  | — |
Other, net | (8.3 | ) |  | 8.2 |  |  | (6.7 | ) |  | 0.3 |  |  | — |  |  | (6.5 | )
Net cash provided used in investing activities | (243.1 | ) |  | (217.8 | ) |  | (121.8 | ) |  | (28.2 | ) |  | (46.5 | ) |  | (657.4 | )
Cash flows from financing activities: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Proceeds from bond issuance | 1,000.0 |  |  | — |  |  | — |  |  | — |  |  | — |  |  | 1,000.0 |
Principal payments on debt, including pre-payments | (517.8 | ) |  | — |  |  | (1.7 | ) |  | — |  |  | — |  |  | (519.5 | )
Principal borrowings on intercompany note payable | — |  |  | — |  |  | — |  |  | 64.0 |  |  | (64.0 | ) |  | — |
Principal payments on intercompany note payable | (17.5 | ) |  | — |  |  | — |  |  | (93.0 | ) |  | 110.5 |  |  | — |
Borrowings on revolving credit facility | 635.0 |  |  | — |  |  | — |  |  | — |  |  | — |  |  | 635.0 |
Payments on revolving credit facility | (620.0 | ) |  | — |  |  | — |  |  | — |  |  | — |  |  | (620.0 | )
Principal payments under finance lease obligations | (0.7 | ) |  | (8.3 | ) |  | (2.6 | ) |  | (7.9 | ) |  | — |  |  | (19.5 | )
Debt amendment and issuance costs | (21.5 | ) |  | — |  |  | — |  |  | — |  |  | — |  |  | (21.5 | )
Repurchases of common stock, including fees and expenses | (45.9 | ) |  | — |  |  | — |  |  | — |  |  | — |  |  | (45.9 | )
Dividends paid on common stock | (108.6 | ) |  | — |  |  | — |  |  | (0.1 | ) |  | — |  |  | (108.7 | )
Purchase of equity interests in consolidated affiliates | (162.9 | ) |  | — |  |  | — |  |  | — |  |  | — |  |  | (162.9 | )
Distributions paid to noncontrolling interests of consolidated affiliates | — |  |  | — |  |  | (79.8 | ) |  | — |  |  | — |  |  | (79.8 | )
Taxes paid on behalf of employees for shares withheld | (15.4 | ) |  | — |  |  | — |  |  | (1.2 | ) |  | — |  |  | (16.6 | )
Contributions from consolidated affiliates | — |  |  | — |  |  | 15.9 |  |  | — |  |  | — |  |  | 15.9 |
Other, net | (4.4 | ) |  | — |  |  | — |  |  | (3.9 | ) |  | — |  |  | (8.3 | )
Change in intercompany advances | 245.8 |  |  | (222.0 | ) |  | (56.5 | ) |  | 32.7 |  |  | — |  |  | — |
Net cash provided by (used in) financing activities | 366.1 |  |  | (230.3 | ) |  | (124.7 | ) |  | (9.4 | ) |  | 46.5 |  |  | 48.2 |
Increase in cash, cash equivalents, and restricted cash | 12.2 |  |  | 2.2 |  |  | 1.4 |  |  | 10.3 |  |  | — |  |  | 26.1 |
Cash, cash equivalents, and restricted cash at beginning of year | 41.5 |  |  | 3.0 |  |  | 69.4 |  |  | 19.6 |  |  | — |  |  | 133.5 |
Cash, cash equivalents and restricted cash at end of year | $ | 53.7 |  |  | $ | 5.2 |  |  | $ | 70.8 |  |  | $ | 29.9 |  |  | $ | — |  |  | $ | 159.6 |
Reconciliation of Cash, Cash Equivalents, and Restricted Cash |  |  |  |  |  |  |  |  |  |  |
Cash and cash equivalents at beginning of period | $ | 41.5 |  |  | $ | 3.0 |  |  | $ | 5.1 |  |  | $ | 19.6 |  |  | $ | — |  |  | $ | 69.2 |
Restricted cash at beginning of period | — |  |  | — |  |  | 59.0 |  |  | — |  |  | — |  |  | 59.0 |
Restricted cash included in other long-term assets at beginning of period | — |  |  | — |  |  | 5.3 |  |  | — |  |  | — |  |  | 5.3 |
Cash, cash equivalents, and restricted cash at beginning of period | $ | 41.5 |  |  | $ | 3.0 |  |  | $ | 69.4 |  |  | $ | 19.6 |  |  | $ | — |  |  | $ | 133.5 |
Cash and cash equivalents at end of period | $ | 53.7 |  |  | $ | 5.2 |  |  | $ | 6.0 |  |  | $ | 29.9 |  |  | $ | — |  |  | $ | 94.8 |
Restricted cash at end of period | — |  |  | — |  |  | 57.4 |  |  | — |  |  | — |  |  | 57.4 |
Restricted cash included in other long-term assets at end of period | — |  |  | — |  |  | 7.4 |  |  | — |  |  | — |  |  | 7.4 |
Cash, cash equivalents, and restricted cash at end of period | $ | 53.7 |  |  | $ | 5.2 |  |  | $ | 70.8 |  |  | $ | 29.9 |  |  | $ | — |  |  | $ | 159.6 |
Supplemental schedule of noncash financing activity: |  |  |  |  |  |  |  |  |  |  |
Intercompany note activity | $ | (232.9 | ) |  | $ | — |  |  | $ | — |  |  | $ | 232.9 |  |  | $ | — |  |  | $ | — |
| For the Year Ended December 31, 2018
| Encompass Health Corporation |  | Guarantor Subsidiaries |  | Non-guarantor Subsidiaries |  | Holdings |  | Eliminating Entries |  | Encompass Health Consolidated
| (In Millions)
Net cash (used in) provided by operating activities | $ | (11.3 | ) |  | $ | 422.2 |  |  | $ | 259.0 |  |  | $ | 92.5 |  |  | $ | — |  |  | $ | 762.4 |
Cash flows from investing activities: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Acquisition of businesses, net of cash acquired | (131.4 | ) |  | — |  |  | — |  |  | (12.5 | ) |  | — |  |  | (143.9 | )
Purchases of property and equipment | (34.1 | ) |  | (133.9 | ) |  | (79.9 | ) |  | (6.6 | ) |  | — |  |  | (254.5 | )
Additions to capitalized software costs | (14.1 | ) |  | (0.1 | ) |  | — |  |  | (1.8 | ) |  | — |  |  | (16.0 | )
Purchases of intangible assets | (2.5 | ) |  | — |  |  | (0.1 | ) |  | (3.1 | ) |  | — |  |  | (5.7 | )
Proceeds from sale of restricted investments | — |  |  | — |  |  | 11.6 |  |  | — |  |  | — |  |  | 11.6 |
Purchases of restricted investments | — |  |  | — |  |  | (13.3 | ) |  | — |  |  | — |  |  | (13.3 | )
Proceeds from repayment of intercompany note receivable | 87.0 |  |  | — |  |  | — |  |  | — |  |  | (87.0 | ) |  | — |
Other, net | (6.0 | ) |  | 2.8 |  |  | — |  |  | 0.5 |  |  | — |  |  | (2.7 | )
Net cash used in investing activities | (101.1 | ) |  | (131.2 | ) |  | (81.7 | ) |  | (23.5 | ) |  | (87.0 | ) |  | (424.5 | )
Cash flows from financing activities: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Principal payments on debt, including pre-payments | (17.6 | ) |  | — |  |  | (3.0 | ) |  | — |  |  | — |  |  | (20.6 | )
Principal payments on intercompany notes payable | — |  |  | — |  |  | — |  |  | (87.0 | ) |  | 87.0 |  |  | — |
Borrowings on revolving credit facility | 325.0 |  |  | — |  |  | — |  |  | — |  |  | — |  |  | 325.0 |
Payments on revolving credit facility | (390.0 | ) |  | — |  |  | — |  |  | — |  |  | — |  |  | (390.0 | )
Principal payments under finance lease obligations | — |  |  | (8.4 | ) |  | (4.2 | ) |  | (5.3 | ) |  | — |  |  | (17.9 | )
Debt amendment and issuance costs | — |  |  | — |  |  | (0.1 | ) |  | — |  |  | — |  |  | (0.1 | )
Dividends paid on common stock | (100.7 | ) |  | — |  |  | — |  |  | (0.1 | ) |  | — |  |  | (100.8 | )
Purchase of equity interests in consolidated affiliates | (65.1 | ) |  | — |  |  | — |  |  | — |  |  | — |  |  | (65.1 | )
Distributions paid to noncontrolling interests of consolidated affiliates | — |  |  | — |  |  | (75.4 | ) |  | — |  |  | — |  |  | (75.4 | )
Taxes paid on behalf of employees for shares withheld | (7.4 | ) |  | — |  |  | — |  |  | (0.9 | ) |  | — |  |  | (8.3 | )
Contributions from consolidated affiliates | — |  |  | — |  |  | 12.6 |  |  | — |  |  | — |  |  | 12.6 |
Other, net | 3.0 |  |  | — |  |  | 13.2 |  |  | 3.2 |  |  | — |  |  | 19.4 |
Change in intercompany advances | 372.4 |  |  | (282.5 | ) |  | (118.9 | ) |  | 29.0 |  |  | — |  |  | — |
Net cash provided by (used in) financing activities | 119.6 |  |  | (290.9 | ) |  | (175.8 | ) |  | (61.1 | ) |  | 87.0 |  |  | (321.2 | )
Increase in cash, cash equivalents, and restricted cash | 7.2 |  |  | 0.1 |  |  | 1.5 |  |  | 7.9 |  |  | — |  |  | 16.7 |
Cash, cash equivalents, and restricted cash at beginning of year | 34.3 |  |  | 2.9 |  |  | 67.9 |  |  | 11.7 |  |  | — |  |  | 116.8 |
Cash, cash equivalents, and restricted cash at end of year | $ | 41.5 |  |  | $ | 3.0 |  |  | $ | 69.4 |  |  | $ | 19.6 |  |  | $ | — |  |  | $ | 133.5 |
Reconciliation of Cash, Cash Equivalents, and Restricted Cash |  |  |  |  |  |  |  |  |  |  |
Cash and cash equivalents at beginning of period | $ | 34.3 |  |  | $ | 2.9 |  |  | $ | 5.5 |  |  | $ | 11.7 |  |  | $ | — |  |  | $ | 54.4 |
Restricted cash at beginning of period | — |  |  | — |  |  | 62.4 |  |  | — |  |  | — |  |  | 62.4 |
Cash, cash equivalents, and restricted cash at beginning of period | $ | 34.3 |  |  | $ | 2.9 |  |  | $ | 67.9 |  |  | $ | 11.7 |  |  | $ | — |  |  | $ | 116.8 |
Cash and cash equivalents at end of period | $ | 41.5 |  |  | $ | 3.0 |  |  | $ | 5.1 |  |  | $ | 19.6 |  |  | $ | — |  |  | $ | 69.2 |
Restricted cash at end of period | — |  |  | — |  |  | 59.0 |  |  | — |  |  | — |  |  | 59.0 |
Restricted cash included in other long-term assets at end of period | — |  |  | — |  |  | 5.3 |  |  | — |  |  | — |  |  | 5.3 |
Cash, cash equivalents, and restricted cash at end of period | $ | 41.5 |  |  | $ | 3.0 |  |  | $ | 69.4 |  |  | $ | 19.6 |  |  | $ | — |  |  | $ | 133.5 |
Supplemental schedule of noncash investing activities: |  |  |  |  |  |  |  |  |  |  |
Intercompany note activity | $ | (136.8 | ) |  | $ | — |  |  | $ | — |  |  | $ | 136.8 |  |  | $ | — |  |  | $ | — |
| For the Year Ended December 31, 2017
| Encompass Health Corporation |  | Guarantor Subsidiaries |  | Non-guarantor Subsidiaries |  | Holdings |  | Eliminating Entries |  | Encompass Health Consolidated
| (In Millions)
Net cash provided by operating activities | $ | 28.2 |  |  | $ | 385.9 |  |  | $ | 181.2 |  |  | $ | 63.0 |  |  | $ | — |  |  | $ | 658.3 |
Cash flows from investing activities: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Acquisition of businesses, net of cash acquired | (10.9 | ) |  | — |  |  | — |  |  | (27.9 | ) |  | — |  |  | (38.8 | )
Purchases of property and equipment | (39.4 | ) |  | (106.5 | ) |  | (75.4 | ) |  | (4.5 | ) |  | — |  |  | (225.8 | )
Additions to capitalized software costs | (16.3 | ) |  | (0.3 | ) |  | (0.1 | ) |  | (2.5 | ) |  | — |  |  | (19.2 | )
Purchases of intangible assets | — |  |  | — |  |  | — |  |  | (3.7 | ) |  | — |  |  | (3.7 | )
Proceeds from sale of restricted investments | — |  |  | — |  |  | 4.2 |  |  | — |  |  | — |  |  | 4.2 |
Purchases of restricted investments | — |  |  | — |  |  | (8.5 | ) |  | — |  |  | — |  |  | (8.5 | )
Proceeds from repayment of intercompany note receivable | 51.0 |  |  | — |  |  | — |  |  | — |  |  | (51.0 | ) |  | — |
Other, net | (3.7 | ) |  | 11.7 |  |  | 0.2 |  |  | 0.6 |  |  | — |  |  | 8.8 |
Net cash used in investing activities | (19.3 | ) |  | (95.1 | ) |  | (79.6 | ) |  | (38.0 | ) |  | (51.0 | ) |  | (283.0 | )
Cash flows from financing activities: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Principal payments on debt, including pre-payments | (126.9 | ) |  | — |  |  | (3.0 | ) |  | — |  |  | — |  |  | (129.9 | )
Principal payments on intercompany notes payable | — |  |  | — |  |  | — |  |  | (51.0 | ) |  | 51.0 |  |  | — |
Borrowings on revolving credit facility | 273.3 |  |  | — |  |  | — |  |  | — |  |  | — |  |  | 273.3 |
Payments on revolving credit facility | (330.3 | ) |  | — |  |  | — |  |  | — |  |  | — |  |  | (330.3 | )
Principal payments under finance lease obligations | — |  |  | (7.3 | ) |  | (3.9 | ) |  | (4.1 | ) |  | — |  |  | (15.3 | )
Debt amendment and issuance costs | (4.1 | ) |  | — |  |  | — |  |  | — |  |  | — |  |  | (4.1 | )
Repurchases of common stock, including fees and expenses | (38.1 | ) |  | — |  |  | — |  |  | — |  |  | — |  |  | (38.1 | )
Dividends paid on common stock | (91.5 | ) |  | — |  |  | — |  |  | — |  |  | — |  |  | (91.5 | )
Proceeds from exercising stock warrants | 26.6 |  |  | — |  |  | — |  |  | — |  |  | — |  |  | 26.6 |
Distributions paid to noncontrolling interests of consolidated affiliates | — |  |  | — |  |  | (51.9 | ) |  | — |  |  | — |  |  | (51.9 | )
Taxes paid on behalf of employees for shares withheld | (19.5 | ) |  | — |  |  | — |  |  | (0.3 | ) |  | — |  |  | (19.8 | )
Contributions from consolidated affiliates | — |  |  | — |  |  | 20.8 |  |  | — |  |  | — |  |  | 20.8 |
Other, net | 1.0 |  |  | — |  |  | — |  |  | (0.7 | ) |  | — |  |  | 0.3 |
Change in intercompany advances | 314.3 |  |  | (282.2 | ) |  | (62.0 | ) |  | 29.9 |  |  | — |  |  | — |
Net cash provided by (used in) financing activities | 4.8 |  |  | (289.5 | ) |  | (100.0 | ) |  | (26.2 | ) |  | 51.0 |  |  | (359.9 | )
Increase in cash, cash equivalents, and restricted cash | 13.7 |  |  | 1.3 |  |  | 1.6 |  |  | (1.2 | ) |  | — |  |  | 15.4 |
Cash, cash equivalents, and restricted cash at beginning of year | 20.6 |  |  | 1.6 |  |  | 66.3 |  |  | 12.9 |  |  | — |  |  | 101.4 |
Cash, cash equivalents, and restricted cash at end of year | $ | 34.3 |  |  | $ | 2.9 |  |  | $ | 67.9 |  |  | $ | 11.7 |  |  | $ | — |  |  | $ | 116.8 |
Reconciliation of Cash, Cash Equivalents, and Restricted Cash |  |  |  |  |  |  |  |  |  |  |
Cash and cash equivalents at beginning of period | $ | 20.6 |  |  | $ | 1.6 |  |  | $ | 5.4 |  |  | $ | 12.9 |  |  | $ | — |  |  | $ | 40.5 |
Restricted cash at beginning of period | — |  |  | — |  |  | 60.9 |  |  | — |  |  | — |  |  | 60.9 |
Cash, cash equivalents, and restricted cash at beginning of period | $ | 20.6 |  |  | $ | 1.6 |  |  | $ | 66.3 |  |  | $ | 12.9 |  |  | $ | — |  |  | $ | 101.4 |
Cash and cash equivalents at end of period | $ | 34.3 |  |  | $ | 2.9 |  |  | $ | 5.5 |  |  | $ | 11.7 |  |  | $ | — |  |  | $ | 54.4 |
Restricted cash at end of period | — |  |  | — |  |  | 62.4 |  |  | — |  |  | — |  |  | 62.4 |
Cash, cash equivalents, and restricted cash at end of period | $ | 34.3 |  |  | $ | 2.9 |  |  | $ | 67.9 |  |  | $ | 11.7 |  |  | $ | — |  |  | $ | 116.8 |
Supplemental schedule of noncash financing activities: |  |  |  |  |  |  |  |  |  |  |
Intercompany note activity | $ | (8.8 | ) |  | $ | — |  |  | $ | — |  |  | $ | 8.8 |  |  | $ | — |  |  | $ | — |
Conversion of convertible debt | 319.4 |  |  | — |  |  | — |  |  | — |  |  | — |  |  | 319.4 |

X
- References No definition available. + Details
Name: | srt_CondensedFinancialInformationOfParentCompanyOnlyDisclosureAbstract
Namespace Prefix: | srt_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for condensed financial information, including the financial position, cash flows, and the results of operations of the registrant (parent company) as of the same dates or for the same periods for which audited consolidated financial statements are being presented. Alternatively, the details of this disclosure can be reported by the specific parent company taxonomy elements, indicating the appropriate date and period contexts in an instance document. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 235 -SubTopic 10 -Section S99 -Paragraph 3 -Subparagraph (SX 210.12-04) -URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e24072-122690 Reference 2: http://www.xbrl.org/2003/role/recommendedDisclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 810 -SubTopic 10 -Section 45 -Paragraph 11 -URI http://asc.fasb.org/extlink&oid=108774443&loc=d3e5283-111683 + Details
Name: | us-gaap_CondensedFinancialInformationOfParentCompanyOnlyDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration